Literature DB >> 10419508

Structural conservation of the pores of calcium-activated and voltage-gated potassium channels determined by a sea anemone toxin.

H Rauer1, M Pennington, M Cahalan, K G Chandy.   

Abstract

The structurally defined sea anemone peptide toxins ShK and BgK potently block the intermediate conductance, Ca(2+)-activated potassium channel IKCa1, a well recognized therapeutic target present in erythrocytes, human T-lymphocytes, and the colon. The well characterized voltage-gated Kv1.3 channel in human T-lymphocytes is also blocked by both peptides, although ShK has a approximately 1,000-fold greater affinity for Kv1.3 than IKCa1. To gain insight into the architecture of the toxin receptor in IKCa1, we used alanine-scanning in combination with mutant cycle analyses to map the ShK-IKCa1 interface, and compared it with the ShK-Kv1.3 interaction surface. ShK uses the same five core residues, all clustered around the critical Lys(22), to interact with IKCa1 and Kv1.3, although it relies on a larger number of contacts to stabilize its weaker interactions with IKCa1 than with Kv1.3. The toxin binds to IKCa1 in a region corresponding to the external vestibule of Kv1.3, and the turret and outer pore of the structurally defined bacterial potassium channel, KcsA. Based on the NMR structure of ShK, we deduce the toxin receptor in IKCa1 to have x-y dimensions of approximately 22 A, a diameter of approximately 31 A, and a depth of approximately 8 A; we estimate that the ion selectivity lies approximately 13 A below the outer lip of the toxin receptor. These dimensions are in good agreement with those of the KcsA channel determined from its crystal structure, and the inferred structure of Kv1.3 based on mapping with scorpion toxins. Thus, these distantly related channels exhibit architectural similarities in the outer pore region. This information could facilitate development of specific and potent modulators of the therapeutically important IKCa1 channel.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10419508     DOI: 10.1074/jbc.274.31.21885

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

Review 1.  Molecular properties and physiological roles of ion channels in the immune system.

Authors:  M D Cahalan; H Wulff; K G Chandy
Journal:  J Clin Immunol       Date:  2001-07       Impact factor: 8.317

2.  Design and synthesis of type-III mimetics of ShK toxin.

Authors:  Jonathan B Baell; Andrew J Harvey; Raymond S Norton
Journal:  J Comput Aided Mol Des       Date:  2002-04       Impact factor: 3.686

3.  New Sea Anemone Toxin RTX-VI Selectively Modulates Voltage-Gated Sodium Channels.

Authors:  R S Kalina; S Peigneur; I N Gladkikh; P S Dmitrenok; N Y Kim; E V Leychenko; M M Monastyrnaya; J Tytgat; E P Kozlovskaya
Journal:  Dokl Biochem Biophys       Date:  2020-12-25       Impact factor: 0.788

4.  Chemical synthesis and 1H-NMR 3D structure determination of AgTx2-MTX chimera, a new potential blocker for Kv1.2 channel, derived from MTX and AgTx2 scorpion toxins.

Authors:  Cyril Pimentel; Sarrah M'Barek; Violetta Visan; Stephan Grissmer; François Sampieri; Jean-Marc Sabatier; Hervé Darbon; Ziad Fajloun
Journal:  Protein Sci       Date:  2007-11-27       Impact factor: 6.725

5.  Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytes.

Authors:  M W Pennington; C Beeton; C A Galea; B J Smith; V Chi; K P Monaghan; A Garcia; S Rangaraju; A Giuffrida; D Plank; G Crossley; D Nugent; I Khaytin; Y Lefievre; I Peshenko; C Dixon; S Chauhan; A Orzel; T Inoue; X Hu; R V Moore; R S Norton; K G Chandy
Journal:  Mol Pharmacol       Date:  2009-01-02       Impact factor: 4.436

6.  Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes.

Authors:  Ildikò Szabó; Jürgen Bock; Heike Grassmé; Matthias Soddemann; Barbara Wilker; Florian Lang; Mario Zoratti; Erich Gulbins
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-25       Impact factor: 11.205

Review 7.  K+ channel modulators for the treatment of neurological disorders and autoimmune diseases.

Authors:  Heike Wulff; Boris S Zhorov
Journal:  Chem Rev       Date:  2008-05       Impact factor: 60.622

8.  Potassium channel modulation by a toxin domain in matrix metalloprotease 23.

Authors:  Srikant Rangaraju; Keith K Khoo; Zhi-Ping Feng; George Crossley; Daniel Nugent; Ilya Khaytin; Victor Chi; Cory Pham; Peter Calabresi; Michael W Pennington; Raymond S Norton; K George Chandy
Journal:  J Biol Chem       Date:  2009-12-04       Impact factor: 5.157

9.  Modulation of Lymphocyte Potassium Channel KV1.3 by Membrane-Penetrating, Joint-Targeting Immunomodulatory Plant Defensin.

Authors:  Seow Theng Ong; Saumya Bajaj; Mark R Tanner; Shih Chieh Chang; Bankala Krishnarjuna; Xuan Rui Ng; Rodrigo A V Morales; Ming Wei Chen; Dahai Luo; Dharmeshkumar Patel; Sabina Yasmin; Jeremy Jun Heng Ng; Zhong Zhuang; Hai M Nguyen; Abbas El Sahili; Julien Lescar; Rahul Patil; Susan A Charman; Edward G Robins; Julian L Goggi; Peng Wen Tan; Pragalath Sadasivam; Boominathan Ramasamy; Siddana V Hartimath; Vikas Dhawan; Janna Bednenko; Paul Colussi; Heike Wulff; Michael W Pennington; Serdar Kuyucak; Raymond S Norton; Christine Beeton; K George Chandy
Journal:  ACS Pharmacol Transl Sci       Date:  2020-05-14

10.  A C-terminally amidated analogue of ShK is a potent and selective blocker of the voltage-gated potassium channel Kv1.3.

Authors:  Michael W Pennington; M Harunur Rashid; Rajeev B Tajhya; Christine Beeton; Serdar Kuyucak; Raymond S Norton
Journal:  FEBS Lett       Date:  2012-10-09       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.